23andMe has gotten the go-ahead from the US Food and Drug Administration to sell its genetic health risk report on three BRCA1 and BRCA2 mutations that increase a person's chances of developing breast cancer, as GenomeWeb reports. These variants are most common among people of Ashkenazi Jewish descent, though they are found to a lesser degree among individuals of other ethnic backgrounds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.